Log In Sign up
The largest database of trusted experimental protocols

Anti vangl2 n 13

Manufactured by Santa Cruz Biotechnology
Visit Supplier

Anti-Vangl2 N-13 is a primary antibody that targets the N-terminus of the Vangl2 protein. Vangl2 is a core component of the planar cell polarity (PCP) pathway and plays a role in the establishment of cell polarity and the regulation of tissue morphogenesis.

Automatically generated - may contain errors

Lab products found in correlation

Anti v5, by Thermo Fisher Scientific (2 mentions) Anti rac1, by Santa Cruz Biotechnology (2 mentions) Anti β catenin, by Cell Signaling Technology (2 mentions) Anti phospho β catenin ser552, by Cell Signaling Technology (2 mentions) Anti actin ac 15, by Merck Group (2 mentions) Anti egfr 1005, by Santa Cruz Biotechnology (2 mentions) Anti muc4 p 20, by Santa Cruz Biotechnology (2 mentions) Anti ha 12ca5 for ub ha, by Roche (2 mentions) Anti rhoa, by BD (2 mentions) Anti flrf rnf41 nrdp1, by Fortis Life Sciences (2 mentions) Anti ha c29f4, by Fortis Life Sciences (2 mentions) Anti tubulin, by Merck Group (2 mentions) Anti dvl2, by Cell Signaling Technology (2 mentions) Anti flag m2, by Merck Group (2 mentions)

2 protocols using anti vangl2 n 13

1

Characterization of Vangl2 and Wnt Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were from ATCC, and T98G, U87-MG, A1207, and U251 cells were gifts from Dr. Paul Knoepfler. T98G, U87-MG and U251 cells were authenticated by Arizona Research Labs (http://uagc.arl.arizona.edu/). Antibodies employed were anti-Vangl2 N-13, anti-Muc4 P-20, anti-Rac1, anti-EGFR (1005) from Santa Cruz, anti-FLAG M2, anti-tubulin, anti-actin AC-15 from Sigma, anti-HA 12CA5 for Ub-HA from Roche, anti-Myc 9E10 from Calbiochem, anti-V5 from Invitrogen, anti-RhoA from BD Biosciences, anti-FLRF/RNF41/Nrdp1 from Bethyl Laboratories, anti-HA C29F4 for Fzd7-HA western blots, anti-Dvl2, anti-phospho-JNK (T183/Y185), anti-phospho-Erk (T202/Y204), anti-phospho-Akt (S473), anti-phospho-β-catenin (Ser33/37/Thr41), anti-phospho-β-catenin (Ser552), and anti-β-catenin from Cell Signaling.
Wald J.H., Hatakeyama J., Printsev I., Cuevas A., Fry W.H., Saldana M.J., Vorst K.V., Rowson-Hodel A., Angelastro J.M., Sweeney C, & Carraway KL I.I.I. (2017). Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination. Oncogene, 36(36), 5158-5167.
+ Open protocol
+ Expand
2

Characterization of Vangl2 and Wnt Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were from ATCC, and T98G, U87-MG, A1207, and U251 cells were gifts from Dr. Paul Knoepfler. T98G, U87-MG and U251 cells were authenticated by Arizona Research Labs (http://uagc.arl.arizona.edu/). Antibodies employed were anti-Vangl2 N-13, anti-Muc4 P-20, anti-Rac1, anti-EGFR (1005) from Santa Cruz, anti-FLAG M2, anti-tubulin, anti-actin AC-15 from Sigma, anti-HA 12CA5 for Ub-HA from Roche, anti-Myc 9E10 from Calbiochem, anti-V5 from Invitrogen, anti-RhoA from BD Biosciences, anti-FLRF/RNF41/Nrdp1 from Bethyl Laboratories, anti-HA C29F4 for Fzd7-HA western blots, anti-Dvl2, anti-phospho-JNK (T183/Y185), anti-phospho-Erk (T202/Y204), anti-phospho-Akt (S473), anti-phospho-β-catenin (Ser33/37/Thr41), anti-phospho-β-catenin (Ser552), and anti-β-catenin from Cell Signaling.
Wald J.H., Hatakeyama J., Printsev I., Cuevas A., Fry W.H., Saldana M.J., Vorst K.V., Rowson-Hodel A., Angelastro J.M., Sweeney C, & Carraway KL I.I.I. (2017). Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination. Oncogene, 36(36), 5158-5167.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!